| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 146, 481-490, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
A Benito, D Grillot, G Nunez and JL Fernandez-Luna
Servicio de Inmunologia, Hospital Universitario Marques de Valdecilla, Santander, Spain.
Polymorphonuclear leukocytes are generated by differentiation of early myeloid precursors. Once fully differentiated, blood neutrophils are programmed to die rapidly and are removed by tissue macrophages. In normal myeloid cells, the death mechanism seems to be coupled to the differentiation pathway and is accomplished by a process termed apoptosis. In the present study, we have examined the role of Bcl-2 in the differentiation pathways of the promyelocytic cell line HL-60. Treatment of HL-60 with retinoic acid or phorbol ester, which induced neutrophil or macrophage-like cell differentiation, respectively, resulted in progressive loss of cellular viability and internucleosomal DNA degradation. In HL-60, differentiation and apoptosis were coupled to down-regulation of the Bcl-2 protein. Overexpression of Bcl-2 by gene transfer inhibited apoptosis triggered by terminal differentiation of HL-60. Yet, Bcl-2 did not alter the expression of surface markers or other phenotypic changes that are induced upon myeloid differentiation. In contrast to HL-60, another immature myeloid cell line, K562, did not produce Bcl-2 but expressed a related protein, Bcl-xL, that functions as a repressor of apoptotic cell death. K562 has been shown to be relatively resistant to a variety of apoptotic stimuli. Incubation of HL-60 and K562 with inhibitors of macromolecular synthesis induced apoptosis, which appeared earlier in HL-60 than in K562. Interestingly, Bcl-2 overexpression protected K562 cells from apoptosis induced by inhibitor of macromolecular synthesis but it had little or no effect on HL-60 cells. We conclude that although differentiation and apoptosis proceed simultaneously, they can be uncoupled by expression of Bcl-2. Down-regulation of Bcl-2 appears to be part of the differentiation pathway and may serve to facilitate the apoptotic response.
This article has been cited by other articles:
 |
|
 |
|
  M. Pelletier, A. Bouchard, and D. Girard In Vivo and In Vitro Roles of IL-21 in Inflammation J. Immunol., December 15, 2004; 173(12): 7521 - 7530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Real, Y. Cao, R. Wang, Z. Nikolovska-Coleska, J. Sanz-Ortiz, S. Wang, and J. L. Fernandez-Luna Breast Cancer Cells Can Evade Apoptosis-Mediated Selective Killing by a Novel Small Molecule Inhibitor of Bcl-2 Cancer Res., November 1, 2004; 64(21): 7947 - 7953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Renshaw, R. M. Orr, M. I. Walton, R. te Poele, R. D. Williams, E. V. Wancewicz, B. P. Monia, P. Workman, and K. Pritchard-Jones Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: Antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival Mol. Cancer Ther., November 1, 2004; 3(11): 1467 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Carlsson, A. A. G. Aprikyan, R. Tehranchi, D. C. Dale, A. Porwit, E. Hellstrom-Lindberg, J. Palmblad, J.-I. Henter, and B. Fadeel Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells Blood, May 1, 2004; 103(9): 3355 - 3361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pipaon, P. Gutierrez, J. C. Montero, M. Lorenzo, A. Eguiraun, J. A. De la Fuente, A. Pandiella, J. Leon, and J. M. Ortiz Mitogen-activated Protein Kinase Routes as Targets in the Action of Diaza-anthracene Compounds with a Potent Growth-inhibitory Effect on Cancer Cells Mol. Cancer Ther., August 1, 2002; 1(10): 811 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sanz, A. Benito, N. Inohara, D. Ekhterae, G. Nunez, and J. L. Fernandez-Luna Specific and rapid induction of the proapoptotic protein Hrk after growth factor withdrawal in hematopoietic progenitor cells Blood, May 1, 2000; 95(9): 2742 - 2747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Hegde, J. Zhao, R. A. Ashmun, and L. H. Shapiro c-Maf Induces Monocytic Differentiation and Apoptosis in Bipotent Myeloid Progenitors Blood, September 1, 1999; 94(5): 1578 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Weinmann, P. Gaehtgens, and B. Walzog Bcl-Xl- and Bax-alpha -Mediated Regulation of Apoptosis of Human Neutrophils Via Caspase-3 Blood, May 1, 1999; 93(9): 3106 - 3115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Oritani, Y. Tomiyama, P. W. Kincade, K. Aoyama, T. Yokota, I. Matsumura, Y. Kanakura, K. Nakajima, T. Hirano, and Y. Matsuzawa Both Stat3-Activation and Stat3-Independent BCL2 Downregulation Are Important for Interleukin-6-Induced Apoptosis of 1A9-M Cells Blood, February 15, 1999; 93(4): 1346 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Guenechea, J.C. Segovia, B. Albella, M. Lamana, M. Ramirez, C. Regidor, M.N. Fernandez, and J.A. Bueren Delayed Engraftment of Nonobese Diabetic/Severe Combined Immunodeficient Mice Transplanted With Ex Vivo-Expanded Human CD34+ Cord Blood Cells Blood, February 1, 1999; 93(3): 1097 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Silva, C. Richard, A. Benito, C. Sanz, I. Olalla, and J. L. Fernandez-Luna Expression of Bcl-x in Erythroid Precursors from Patients with Polycythemia Vera N. Engl. J. Med., February 26, 1998; 338(9): 564 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sanz, A. Benito, M. Silva, B. Albella, C. Richard, J. C. Segovia, A. Insunza, J. A. Bueren, and J. L. Fernandez-Luna The Expression of Bcl-x Is Downregulated During Differentiation of Human Hematopoietic Progenitor Cells Along the Granulocyte But Not the Monocyte/Macrophage Lineage Blood, May 1, 1997; 89(9): 3199 - 3204. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
